Evaluation of the effect of single-shot high dosed antithrombin in deceased donor kidney transplantation on ischemia/reperfusion injury and safety in a single center controlled randomized trial
Phase 4
- Conditions
- End-stage renal failure
- Registration Number
- JPRN-UMIN000007864
- Lead Sponsor
- udwig-Maximilians-University Munich, Germany
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
ongoing medication with anticoagulant drugs with the exception of acetylsalicylic acid, positive history of bleeding/procoagulant disorders (hereditary AT-deficiency, factor-V-Leiden mutation, prothrombin mutation, antiphospholipid syndromes, deficiency of protein C or protein S)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method